Genetic testing for glucocorticoid-remediable aldosteronism was suggested for patients diagnosed with primary aldosteronism before age 20 years or for those with a family history of primary ...

Glucocorticoid-remediable aldosteronism (GRA) is a monogenic form of human hypertension that predisposes to cerebral hemorrhage. As a result of a chimeric gene duplication, aldosterone is ectopically ...

Glucocorticoid Remediable Aldosteronism (GRA), also known as familial hyperaldosteronim type I (FH-I) is a form of inherited hypertension, transmitted as an autosomal dominant trait. The syndrome ...

Recommendations for screening crucially depend on the diagnostic and therapeutic setting. We do not agree with the authors’ statement that aldosteronism is “a relatively common cause of resistant ...

The Endocrine Society released clinical practice guidelines for the diagnosis and management of primary aldosteronism in the September issue of the Journal of Clinical Endocrinology & Metabolism.

The Primary Aldosteronism Medical Treatment Outcome (PAMO) criteria provide a standardized approach to assess medical treatment outcomes for primary aldosteronism, according to study results published ...

The cause is unknown, but this condition accounts for 60% to 70% of primary aldosteronism cases. A benign, aldosterone-producing adrenal tumor on one of the adrenal glands is the underlying cause in ...

9. Shahrrava A, Moinuddin S, Boddu P, Shah R. A case of glucocorticoid remediable aldosteronism and thoracoabdominal aneurysms. Case Rep Endocrinol. (2016) 2016:1–4. doi: 10.1155/2016/2017571.